Abstract:Fisetin is a flavonoid that exhibits high antioxidant activity and is widely employed in the pharmacological industries. However, the application of fisetin is limited due to its low water solubility. In this study, glycoside derivatives of fisetin were synthesized by an enzymatic reaction using cyclodextrin glycosyltransferase (CGTase) from Paenibacillus sp. RB01 in order to improve the water solubility of fisetin. Under optimal conditions, CGTase was able to convert more than 400 mg/L of fisetin to its glyco… Show more
“…The concentrations required to scavenge 50% of DPPH radical were comparable for fisetin-7-O-glucoside (2.28 µM), fisetin-4 -O-glucoside (2.52 µM) and fisetin (2.72 µM). Transglycosylation did not affect antioxidant activity in this case, unlike in the previous example [134].…”
Section: Comparison Of the Effects Of Fisetin Pre-formulation Modific...contrasting
confidence: 61%
“…The concentrations required to scavenge 50% of DPPH radical were comparable for fisetin-7-O-glucoside (2.28 µM), fisetin-4′-O-glucoside (2.52 µM) and fisetin (2.72 µM). Transglycosylation did not affect antioxidant activity in this case, unlike in the previous example[134].These two studies show that incorporating glucosyl moiety into the fisetin compound significantly improves its solubility, but further evaluation of fisetin derivative properties is needed.…”
As secondary plant metabolites, polyphenols are abundant in fruits and vegetables. They are in high demand because of their many health benefits. However, their low bioavailability makes them complex compounds to use for therapeutic purposes. Due to the limited solubility of phytocompounds, dietary supplements made from them may only be partially effective. Such molecules include fisetin, found in strawberries, and have shown great promise in treating Alzheimer’s disease and cancer. Unfortunately, because of their limited water solubility, low absorption, and poor bioavailability, the assistance of nanotechnology is required to allow them to fulfil their potential fully. Here, we provide evidence that nanodelivery methods and structure modifications can improve fisetin bioavailability, which is linked to improvements in therapeutic efficacy. An open question remains as to which nanocarrier should be chosen to meet the abovementioned requirements and be able to enhance fisetin’s therapeutic potential to treat a particular disease.
“…The concentrations required to scavenge 50% of DPPH radical were comparable for fisetin-7-O-glucoside (2.28 µM), fisetin-4 -O-glucoside (2.52 µM) and fisetin (2.72 µM). Transglycosylation did not affect antioxidant activity in this case, unlike in the previous example [134].…”
Section: Comparison Of the Effects Of Fisetin Pre-formulation Modific...contrasting
confidence: 61%
“…The concentrations required to scavenge 50% of DPPH radical were comparable for fisetin-7-O-glucoside (2.28 µM), fisetin-4′-O-glucoside (2.52 µM) and fisetin (2.72 µM). Transglycosylation did not affect antioxidant activity in this case, unlike in the previous example[134].These two studies show that incorporating glucosyl moiety into the fisetin compound significantly improves its solubility, but further evaluation of fisetin derivative properties is needed.…”
As secondary plant metabolites, polyphenols are abundant in fruits and vegetables. They are in high demand because of their many health benefits. However, their low bioavailability makes them complex compounds to use for therapeutic purposes. Due to the limited solubility of phytocompounds, dietary supplements made from them may only be partially effective. Such molecules include fisetin, found in strawberries, and have shown great promise in treating Alzheimer’s disease and cancer. Unfortunately, because of their limited water solubility, low absorption, and poor bioavailability, the assistance of nanotechnology is required to allow them to fulfil their potential fully. Here, we provide evidence that nanodelivery methods and structure modifications can improve fisetin bioavailability, which is linked to improvements in therapeutic efficacy. An open question remains as to which nanocarrier should be chosen to meet the abovementioned requirements and be able to enhance fisetin’s therapeutic potential to treat a particular disease.
“…Low solubility in water and poor bioavailability may be limiting the use of this molecule in the pharmacological context [9,16]. For this reason, it is important to tailor this molecule into safer, more stable and active derivatives that can aid in the development of FST-based pharmacological strategies and also add to the current understanding of its bioactivities.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.